Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for lung protection in sepsis
NCT02842437Unknown
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Jul 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in sepsis comparing Dexmedetomidine with Placebo (2 arms). Primary endpoints: Alveolar-Arterial Oxygen Difference, Oxygenation Index and 1 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02842437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02842437.